Work

Table S6 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Year: 2023
Type: other
Abstract: Gene expression data after TK-216 treatment (8h) in U2932. A) Supervised analysis of transcriptome after treatment B) Gene-sets significantly enriched after treatment. C) IRF4/SPIB and lenalidomide related gene-sets significantly enriched after treatment.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361887850
Cites:
Cited by:
Related to: 10